Program
Friday, January 20, 2023
09:00 - 09:15 | Welcome Session Thomas Hoffmann (Congress President) Thomas Wirth (Dean of the Medical Faculty) Jens-Peter Klussmann (Speaker of the Oncology Working Group) Stephan Stilgenbauer (Head of the Comprehensive Cancer Center) |
09:15 - 10:40 Chair |
Session 1: Tumor Immunology I Andreas Dietz (Leipzig) / Simon Laban (Ulm) |
09:15 IS 1 |
TOPIC UPDATE by Simon Laban (Ulm) |
09:30 IS 2 |
Cornelis Melief (Leiden, NL) Combination immunotherapy of cancers caused by high risk human papilloma virus |
09:50 IS 3 |
Christian Ottensmeier (Liverpool, GB) Modulation of regulatory T cells in the tumor microenvironment |
10:10 IS 4 |
Kathrin Scheckenbach (Düsseldorf) CAR-T-cells in head and neck cancer |
10:30 OP 1 |
Tina Jost (Erlangen) Inhibition of ATM vs. ATR in combination with radiotherapy affects cellular toxicity and expression of immune checkpoint molecules differently in HNSCC |
10:40 - 11:10 | Coffee break |
11:10 - 12:30 Chair |
Session 2: Molecular Oncology Cornelia Brunner (Ulm) / Jochen Hess (Heidelberg) |
11:10 IS 5 |
Nils Cordes (Dresden) Focal adhesion signaling in HNSCC: Mechanisms and therapeutic exploitability |
11:30 IS 6 |
Per Sonne Holm (Innsbruck, A) Cell cycle inhibition and epigenetic modulation meets YB-1 based virotherapy |
11:50 IS 7 |
Wojciech Golusinski (Posnan, PL) Basic research in head and neck surgery department: connection between the hospital bed and the bench |
12:10 OP 2 |
Felix Broghammer (Dresden) Pan-FGFR targeting elicits radiochemo-sensitization in 3D matrix grown HNSCC cell models |
12:20 OP 3 |
Qiaoli Li (Heidelberg) A KLK6-related gene expression signature predicts survival of HPV-related head and neck cancer |
12:30 - 13:30 | Lunch + Lunch Symposium |
13:30 - 14:30 Chair |
Session 3: Tumor cell signaling Christian Simon (Lausanne, CH) / Chia-Jung Busch (Greifswald) |
13:30 IS 8 |
Jennifer Grandis (San Francisco, USA) Precision Head and Neck Cancer Medicine |
13:50 IS 9 |
Edwin Jackson (Pittsburgh, USA) 8-aminopurines and their role in cancer [ONLINE] |
14:10 OP 4 |
Robert Mandic (Marburg) The possible role of circular RNAs in head and neck cancer |
14:20 OP 5 |
Todor Popov (Sofia, BG) Global microRNA expression profile in laryngeal carcinoma unveils new prognostic biomarkers and novel insights into field cancerization |
14:30 - 15:00 | Coffee break |
15:00 - 16:10 Chair |
Session 4: Tumor Signatures and personalized approaches Olivier Gires (Munich) / Cornelius Kürten (Essen) |
15:00 IS 10 |
Reiner Siebert (Ulm) Lymphomas of the Waldeyer‘s ring |
15:20 IS 11 |
Stefan Fröhling (Heidelberg) Leveraging Multi-Layered Omics Data for Precision Oncology |
15:40 IS 12 |
Dietmar Thurnher (Graz, A) The microbiome in head and neck cancer |
16:00 OP 6 |
Maria Rentschler (Heidelberg) Establishment of sex-related prognostic risk models for females and males with HNSCC |
16:10 - 17:20 Chair |
Session 5: HPV-related Head and Neck Cancer Jens-Peter Klussmann (Cologne) / Christian Betz (Hamburg) |
16:10 IS 13 |
Terry Jones (Liverpool, GB) Emerging Insights On The Genetic Map Of Head-neck Cancer [ONLINE] |
16:30 IS 14 |
Marij Welters (Leiden, NL) Deciphering the tumor microenvironment in HPVneg and HPVpos OPSCC |
16:50 IS 15 |
Carole Fakhry (Baltimore, USA) The role of ctDNA as a liquid biopsy for HNSCC diagnosis and treatment surveillance [ONLINE] |
17:10 OP 7 |
Gunnar Wichmann (Leipzig) Outcome differences in HPV-driven oropharyngeal squamous cell carcinoma attributable to altered Human Leukocyte Antigen frequencies |
17:30 - 18:30 | Poster Session with Wine & Cheese Chairs: Sven Brandau (Essen), Nils Cordes (Dresden), Wojciech Golusinski (Posnan, PL), Jens-Peter Klussmann (Cologne) |
19:30 | Social evening (open end) |
Saturday, January 21, 2023
09:00 - 10:40 Chair |
Session 6: Surgery + Imaging Patrick Schuler (Ulm) / Asit Arora (London) |
09:00 IS 16 |
Umamahesvar Duvvuri (Pittsburgh, USA) new developments in robot-assisted surgery |
09:20 IS 17 |
Drago Prgomet (Zagreb, HR) Lateral neck metastases in thyroid cancer |
09:40 IS 18 |
Max Witjes (Groningen, NL) Image guided surgery in margin assessment using fluorescent tracers |
10:00 IS 19 |
Asit Arora (London, GB) Current practice and updates in management of the cancer unknown primary |
10:20 OP 8 |
Christoph Reichel (Munich) A novel antibody-based approach for image-guided surgery in HNSCC |
10:30 OP 9 |
Franziska Hoffmann (Jena) Current developments for ex-vivo biophotonic Imaging approaches for Head and Neck Cancer diagnosis and therapy |
10:40 - 11:10 | Coffee break |
11:10 - 12:20 Chair |
Session 7: Liquid Biopsy Barbara Wollenberg (Munich) / Laurent Muller (Basel, CH) |
11:10 IS 20 |
Simon Joosse (Hamburg) Liquid Biopsy: From Discovery to Clinical Implementation |
11:30 |
Lisa Wiesmüller (Ulm) Monitoring DNA damage responses in CTCs for prediction of therapeutic responses |
11:50 OP 10 |
Susanne Flach (Munich) Detection of molecular residual disease and recurrence using sensitive personalised ctDNA analysis |
12:00 IS 22 |
TOPIC UPDATE by Theresa Whiteside (Pittsburgh, USA) [ONLINE] |
12:20 - 13:40 Chair |
Session 8: Tumor Immunology II Thomas Hoffmann (Ulm) / Marie-Nicole Theodoraki (Ulm) |
12:20 IS 23 |
Vincent Gregoire (Lyon, F) Protontherapy for HNSCC: a promising new tool or also a way to enhance radiation effect though an immune response? |
12:40 IS 24 |
Sven Brandau (Essen) Immune-mediated mechanisms of tumor progression |
13:00 IS 25 |
Jan Böttcher (Munich) The role of dendritic cells in immunity to head and neck cancers |
13:20 OP 11 |
Sonja Ludwig (Mannheim) Exosomes revert the angiogenic switch in head and neck cancer patients |
13:30 OP 12 |
Christian Doreth (Essen) Neoadjuvant anti PD-L1 therapy induces rapid functional changes in systemic immune functions |
13:40 - 14:00 | Awards & Closing Session Thomas Hoffmann (Congress President) Barbara Wollenberg (Incoming President) |